pore-forming beta-cyclodextrin derivatives (Innovative Biologics)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepore-forming beta-cyclodextrin derivatives (Innovative Biologics)
Drug Alias NameCER002-13IB-201CER001-13CYL-3023
ClassificationSmall molecules
Mechanisms of ActionAlpha-hemolysin inhibitors
TargetsAlpha-hemolysin
Therapy Area/IndicationsClostridium perfringens infectionStaphylococcal InfectionsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnovative Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnovative Biologics Inc
Active IndicationsN/A
Inactive IndicationsClostridium perfringens infectionStaphylococcal InfectionsAnthrax

Other Information

ATC CodeN/A
Related LinksN/A